MiRNA Sequencing And Assay Market Will Approach A Healthy CAGR of 13.0% By 2028, Boosted By Rising Usage in Healthcare Business | Million Insights

November 05 07:25 2021
MiRNA Sequencing And Assay Market Will Approach A Healthy CAGR of 13.0% By 2028, Boosted By Rising Usage in Healthcare Business | Million Insights
Million Insights – World’s Fastest Growing Market Research Database
According to new report available with Million Insights, the global miRNA sequencing & assay industry to grow at fast pace owing to the growth of technically higher sequence analysis stage during the forecast period.

The global miRNA sequencing and assay market size is estimated to arrive at USD 597.8 million by 2028. It is projected to develop by 13.0% CAGR from 2021 to 2028.

Due to the rising use of the miRNA sequencing and assay in the healthcare business, the market grasps a momentous development prospective. Such as, a number of research lessons reveal that miRNA is able to be used like well-organized biomarkers, in the forecast and analysis of nervous system complaints, diagnosis of cancer (cervical, breast, ovarian, and other), sepsis, and cardiovascular sicknesses. As a result, miRNA sequence analysis is progressively more in use for analyzing the gene regulation in experimental disarray.

To download the sample PDF of miRNA Sequencing And Assay Market Report “please” click here: https://www.millioninsights.com/industry-reports/global-mirna-sequencing-assay-market/request-sample


Since, the plasma obtained from the recovered patients of Covid-19, is abundant in antiviral miRNAs as well as antibodies, it has been in use to cure SARS-CoV-2 infected patients. This has caused an augmentation in research lessons, which concentrate on the sequence analysis of miRNA (microRNA) from the virus plus the patient.


To browse report summary & detailed TOC, please click the link below: https://www.millioninsights.com/industry-reports/global-mirna-sequencing-assay-market

Further key findings from the report suggest:

• Since, miRNA sequencing and assay procedures along with the connected products are extensively utilized, in a variety of research readings performed by research and academic institutes, the research and academic institutions are single of the most important revenue producer of the miRNA sequencing and assay market

• Due to the continuing wide-ranging research in cancer, by means of miRNA like a biomarker, to scrutinize the identification as well as forecast of the cancer plus to build up new treatments, the cancer application sector produced the principal revenue share, in 2020

• This expertise is, furthermore, performing significant function in the discovery of the transformations in tumor tissue, that assists to work out the custom-made as well as targeted treatments

• Small and mid-sized research units deal with the fiscal limits, to put in the sequencing apparatuses because of their elevated price tag. As a result, these institutes move toward service supplier. This is anticipated to propel the services sector by means of the highest CAGR, during the forecast period

• The market, in Asia Pacific, is expected to record a well-paid enlargement speed, all the way through the forecast period, because of the excessive unmet clinical requirements, existence of a vast marked inhabitants and rising organizations of the healthcare

• The global rise in the cancer patients, additionally propels the expansion of the sector

• In 2020, the sequencing workflow sector retained the major revenue share and is estimated to observe the highest CAGR, throughout the forecast period because it is the most significant as well as critical stage of the workflow

• Sequencing by synthesis possesses a main share of the technology sector, due to its extreme throughput, greater sensitivity, and quick turnaround period

• The product held the biggest revenue share and led the market, in 2020. The attendance of several companies, which present apparatuses, wide-ranging kits, and consumables for particular purpose, add to the expansion of the sector

Million Insights segmented the global miRNA sequencing and assay market based on End Use, Application, Workflow, Technology, Product & Services, and Region.

miRNA Sequencing And Assay Product & Service Outlook (Revenue, USD Million, 2017 – 2028)

    • Products

        • Library Preparation Kits

        • Sequencing Consumables

        • Instruments

    • Services

miRNA Sequencing And Assay Technology Outlook (Revenue, USD Million, 2017 – 2028)

    • Sequencing (Seq.) By Synthesis

    • Seq. By Oligonucleotide Ligation and Detection (SOLiD)

    • Nanopore Seq.

    • Sanger Seq.

    • Single Molecule Real-time (SMRT) Seq.

miRNA Sequencing And Assay Workflow Outlook (Revenue, USD Million, 2017 – 2028)

    • Library Preparation

    • Sequencing

    • Data Analysis & Storage

miRNA Sequencing And Assay Application Outlook (Revenue, USD Million, 2017 – 2028)

    • Cancer

    • Polyglutamine Diseases

    • Autoimmune Disease

    • Schizophrenia

    • Others

miRNA Sequencing And Assay End-use Outlook (Revenue, USD Million, 2017 – 2028)

    • Pharmaceutical & Biotechnology Industry

    • Research and Academic Institutes

    • Contract Research Organizations

miRNA Sequencing And Assay Regional Outlook (Revenue, USD Million, 2017 – 2028)

    • North America

        • U.S.

        • Canada

    • Europe

        • Germany

        • France

        • U.K.

        • Italy

        • Spain

    • Asia Pacific

        • China

        • Japan

        • India

        • Australia

        • South Korea

    • Latin America

        • Brazil

        • Mexico

    • Middle East Africa (MEA)

        • South Africa

        • Saudi Arabia


Various companies for miRNA sequencing and assay market are:

• System Biosciences, LLC

• HTG Molecular Diagnostics, Inc.

• Norgen Biotek Corp

• Takara Bio Inc.

• Abcam plc


• Thermo Fisher Scientific, Inc.

• Meridian Bioscience, Inc.

• Maravai LifeSciences

• Lexogen GmbH

• New England Biolabs

• PerkinElmer, Inc.

• Illumina, Inc.

Browse the Latest Press Releases Available with Million Insights:

3D Projector Market – The global 3D projector market is anticipated to value USD 4.34 billion until 2025. It is also expected to register a CAGR of 5.4% over the forecasted years, 2019 to 2025.

Server Market The global server market is projected to reach USD 83.06 billion by 2025 and expected to register 5.4% CAGR over the forecast period, from 2019 to 2025.

About Million Insights

Million Insights, is a distributor of market research reports, published by premium publishers only. We have a comprehensive market place that will enable you to compare data points, before you make a purchase. Enabling informed buying is our motto and we strive hard to ensure that our clients get to browse through multiple samples, prior to an investment. Service flexibility & the fastest response time are two pillars, on which our business model is founded. Our market research report store, includes in-depth reports, from across various industry verticals, such as healthcare, technology, chemicals, food & beverages, consumer goods, material science & automotive.

Media Contact
Company Name: Million Insights
Contact Person: Ryan Manuel
Email: Send Email
Phone: 91-20-65300184
Address:Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar
City: Pune
State: Maharashtra
Country: India
Website: https://www.millioninsights.com/industry-reports/global-mirna-sequencing-assay-market